Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
36.80
+0.28 (0.77%)
Apr 14, 2026, 9:39 AM EDT - Market open
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $5.93 billion as of April 14, 2026. Its market cap has increased by 711.14% in one year.
Market Cap
5.93B
Enterprise Value
5.22B
1-Year Change
711.14%
Ranking
Category
Stock Price
$36.80
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $5.93B, an increase of 4,669.18%. That is a compound annual growth rate of 95.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 5.88B | 8.85% |
| Dec 31, 2025 | 5.40B | 527.16% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protagonist Therapeutics | 6.23B |
| Centessa Pharmaceuticals | 6.12B |
| Terns Pharmaceuticals | 6.07B |
| Rhythm Pharmaceuticals | 5.93B |
| PTC Therapeutics | 5.83B |
| Mirum Pharmaceuticals | 5.82B |
| Celcuity | 5.82B |
| CG Oncology | 5.72B |